2024

All Categories

2024

Date Title Document
Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb Date 12/12/24 Title Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb Download pdf
Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day Date 12/05/24 Title Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day Download pdf
Bausch Health Appoints New Chief Medical Officer and Head of R&D Date 12/02/24 Title Bausch Health Appoints New Chief Medical Officer and Head of R&D Download pdf
Bausch Health and Salix to present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a new investigational product designed to address serious complications of cirrhosis Date 11/18/24 Title Bausch Health and Salix to present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a new investigational product designed to address serious complications of cirrhosis Download pdf
Bausch Health Announces Third Quarter 2024 Results Date 10/30/24 Title Bausch Health Announces Third Quarter 2024 Results Download pdf
ACG Presidential Plenary to Highlight Analysis of Xifaxan® (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence Date 10/28/24 Title ACG Presidential Plenary to Highlight Analysis of Xifaxan® (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence Download pdf
Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024 Date 10/09/24 Title Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024 Download pdf
Bausch Health and Salix survey highlights urgent need for improved understanding of liver disease across healthcare provider disciplines as prevalence of cirrhosis rises Date 10/08/24 Title Bausch Health and Salix survey highlights urgent need for improved understanding of liver disease across healthcare provider disciplines as prevalence of cirrhosis rises Download pdf
Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners Date 08/13/24 Title Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners Download pdf
Bausch Health Announces Second Quarter 2024 Results Date 08/01/24 Title Bausch Health Announces Second Quarter 2024 Results Download pdf
Bausch Health Responds to Market Rumors Date 07/24/24 Title Bausch Health Responds to Market Rumors Download pdf
Bausch Health Welcomes Two New Members to the Executive Leadership Team Date 07/19/24 Title Bausch Health Welcomes Two New Members to the Executive Leadership Team Download pdf
Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024 Date 07/11/24 Title Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024 Download pdf
Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals Date 06/20/24 Title Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals Download pdf
Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences Date 06/14/24 Title Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences Download pdf
Bausch Health, Canada Inc. announces additional public drug plan listings for PrUCERIS® (budesonide) aerosol foam to treat mild to moderate distal ulcerative colitis in adults Date 05/23/24 Title Bausch Health, Canada Inc. announces additional public drug plan listings for PrUCERIS® (budesonide) aerosol foam to treat mild to moderate distal ulcerative colitis in adults Download pdf
Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024 Date 05/17/24 Title Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024 Download pdf
Bausch Health Announces 2024 Annual Meeting of Shareholder Results Date 05/15/24 Title Bausch Health Announces 2024 Annual Meeting of Shareholder Results Download pdf
Bausch Health Announces Updates Related to Norwich XIFAXAN Matters Date 05/14/24 Title Bausch Health Announces Updates Related to Norwich XIFAXAN Matters Download pdf
Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan® (rifaximin) Date 05/09/24 Title Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan® (rifaximin) Download pdf
Bausch Health Announces First Quarter 2024 Results Date 05/02/24 Title Bausch Health Announces First Quarter 2024 Results Download pdf
Bausch Health to Announce First-Quarter 2024 Results on May 2 Date 04/11/24 Title Bausch Health to Announce First-Quarter 2024 Results on May 2 Download pdf
Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029 Date 04/11/24 Title Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029 Download pdf
Acne vulgaris treatment PrARAZLO™ (tazarotene lotion, 0.045%) now available to patients through British Columbia PharmaCare public drug plan Date 04/11/24 Title Acne vulgaris treatment PrARAZLO™ (tazarotene lotion, 0.045%) now available to patients through British Columbia PharmaCare public drug plan Download pdf
Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals Date 04/05/24 Title Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals Download pdf
Bausch Health, Canada Inc. announces first public drug plan listings for PrUCERIS® (budesonide) aerosol foam to help address the unmet need for the treatment of mild to moderate distal ulcerative colitis in adults Date 04/03/24 Title Bausch Health, Canada Inc. announces first public drug plan listings for PrUCERIS® (budesonide) aerosol foam to help address the unmet need for the treatment of mild to moderate distal ulcerative colitis in adults Download pdf
Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations Date 04/02/24 Title Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations Download pdf
Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR® (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma Date 03/06/24 Title Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR® (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma Download pdf
New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How to Prepare for the Procedure Date 03/05/24 Title New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How to Prepare for the Procedure Download pdf
Bausch Health Companies to Present at Cowen Annual Health Care Conference Date 03/01/24 Title Bausch Health Companies to Present at Cowen Annual Health Care Conference Download pdf
Bausch Health Announces Fourth-Quarter and Full-Year 2023 Results Date 02/22/24 Title Bausch Health Announces Fourth-Quarter and Full-Year 2023 Results Download pdf
Salix Announces 2024 Gastrointestinal Health Scholars Program Date 02/12/24 Title Salix Announces 2024 Gastrointestinal Health Scholars Program Download pdf
Bausch Health Announces Board Refreshment Date 02/01/24 Title Bausch Health Announces Board Refreshment Download pdf
Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22 Date 02/01/24 Title Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22 Download pdf
CABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S. Date 01/30/24 Title CABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S. Download pdf
Solta Medical’s Thermage® FLX and TR-4 Return Pad Receive Registration Certifications in China Date 01/18/24 Title Solta Medical’s Thermage® FLX and TR-4 Return Pad Receive Registration Certifications in China Download pdf
Court of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute Date 01/08/24 Title Court of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute Download pdf
Powered by Sitecore